• Explore /
  • Poster
  • / Phase I/II trial of pembrolizumab in combination with binimetinib in unresectable locally advanced or metastatic triple negative breast cancer.

Phase I/II trial of pembrolizumab in combination with binimetinib in unresectable locally advanced or metastatic triple negative breast cancer.

Abstract Poster

Authors

Saranya Chumsri

Saranya Chumsri

Mayo Clinic, Jacksonville, FL

Saranya Chumsri, Mei-Yin Polley, Sarah L. Anderson, Ciara Catherine Maria O'Sullivan, Gerardo Colon-Otero, Keith L Knutson, E Aubrey Thompson, Alvaro Moreno-Aspitia

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO-SITC Clinical Immuno-Oncology Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A

Track

Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Breast and Gynecologic Cancers,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Oncolytic Viruses

Sub Track

Immune Checkpoints and Stimulatory Receptors

Clinical Trial Registration Number

NCT03106415

Citation

J Clin Oncol 36, 2018 (suppl 5S; abstr TPS17)

DOI

10.1200/JCO.2018.36.5_suppl.TPS17

Abstract #

TPS17

Poster Bd #

M5

Abstract Disclosures

Similar Posters

First Author: Saranya Chumsri

First Author: Montaser F. Shaheen

First Author: Ana Christina Garrido-Castro

First Author: Kai Sun